The USC Annenberg Inclusion Initiative has published a series of reports ... Smith, who led the study. “It is clear that there are still real discrepancies in who gets to lead… The top of the ...

Lewy body dementia (LBD) is a progressive condition. The average life expectancy is around 5 to 8 years following a diagnosis, but it can be up to 20 years. There is no cure for LBD, but treatment ...

About Inclusion Body Myositis (IBM ... dexterity and mobility. There are currently no available disease-modifying treatment options for IBM. Based on published epidemiology literature, it is ...

About Inclusion Body Myositis (IBM) IBM is an autoimmune disease ... dexterity and mobility. There are currently no available disease-modifying treatment options for IBM. Based on published ...

The most important feature distinguishing inclusion body myositis from the other two inflammatory myopathies is the lack of responsiveness to immunosuppressive treatment. Although most patients ...

IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news ...

Inclusion Body Myositis is a progressive muscle disorder marked ... population exceeding 50,000 in the United States and Europe alone, there is a pressing need for effective treatment options. The ...

“Sleep is essentially recovery for wear and tear on the body that has occurred during ... because it’s not intense. There’s not a risk of falling,” she said. “There are caveats that ...

a first-in-class monoclonal antibody targeting killer cell lectin like receptor G1 (KLRG1), for the treatment of inclusion body myositis (IBM). Meanwhile, AdvanCell came third in the rankings after ...

Objectives To evaluate the effectiveness and safety of upadacitinib in treatment-refractory inflammatory myositis. Methods Patients with refractory inflammatory myositis treated with upadacitinib from ...

Cystic fibrosis (CF) treatment typically ... abnormally throughout the body. In recent years, scientists have developed drugs called CFTR modulators that can improve CFTR function in people with ...